Back to News

³Ô¹Ï±¬ÁÏ AI Agents Now Available to Increase Productivity
and Customer Centricity

³Ô¹Ï±¬ÁÏ AI delivers industry-specific AI for the next chapter in life sciences

PLEASANTON, CA ¡ª 3 Dec. 2025 ¡ª In a major milestone for ³Ô¹Ï±¬ÁÏ AI, industry-specific AI for life sciences, ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) today announced the availability of ³Ô¹Ï±¬ÁÏ AI Agents for Vault CRM and PromoMats. ³Ô¹Ï±¬ÁÏ AI in the ³Ô¹Ï±¬ÁÏ Vault Platform and deep, specialized AI agents working in ³Ô¹Ï±¬ÁÏ applications deliver practical AI with clear business value. Additional ³Ô¹Ï±¬ÁÏ AI Agents for clinical, regulatory, safety, quality, medical, and commercial are planned for release throughout 2026.

¡°With industry-specific ³Ô¹Ï±¬ÁÏ AI Agents working seamlessly in ³Ô¹Ï±¬ÁÏ applications, the life sciences industry can increase productivity, customer centricity, and advance to new ways of working,¡± said Andy Han, senior vice president, ³Ô¹Ï±¬ÁÏ AI. ¡°Thanks to our customers for your collaboration as we rapidly develop practical AI that can have a significant impact on the industry.¡±

³Ô¹Ï±¬ÁÏ AI Now Available for Vault CRM

  • Free Text Agent detects and flags potential issues in call notes to ensure accuracy and compliance. With more in-depth call reporting, companies gain the advantage of richer, higher quality customer insights.
  • Voice Agent enables voice input for Vault CRM so it¡¯s faster and easier for field teams to capture information and follow-up actions.
  • Pre-call Agent provides insights and suggested actions from relevant data, content, activity, and trends that help field reps prepare for calls.

³Ô¹Ï±¬ÁÏ AI Now Available for PromoMats

  • Quick Check Agent scans content using editorial, brand, market, channel, and compliance guidelines to address issues before medical, legal, regulatory (MLR) review.
  • Content Agent provides context-aware insights into document text and images, answers questions, summarizes content, analyzes visuals, and draws from Quick Check Agent to assist with document review.

³Ô¹Ï±¬ÁÏ AI Agents work seamlessly within ³Ô¹Ï±¬ÁÏ applications and have direct, secure access to data, documents, and workflows and operate within established user access controls, permissions, and audit trails. Customers can also configure and extend ³Ô¹Ï±¬ÁÏ-delivered AI Agents and build their own custom agents with ³Ô¹Ï±¬ÁÏ AI.

³Ô¹Ï±¬ÁÏ Business Consulting provides support for the business process design and change management necessary as companies define new business and process flows among users and agents.

For the latest ³Ô¹Ï±¬ÁÏ AI information, customers can visit the ³Ô¹Ï±¬ÁÏ AI Community on and .

What the Industry is Saying About ³Ô¹Ï±¬ÁÏ AI

¡°By embedding AI into every step of the customer journey ¡ª from how practitioners receive valuable information about our portfolio to how they engage with our field force ¡ª ³Ô¹Ï±¬ÁÏ AI is ideally positioned to support us in our mission to deliver life-changing medicines to patients worldwide.¡±

- Greg Meyers, Executive Vice President, Chief Digital and Technology Officer
Bristol Myers Squibb

¡°What we¡¯ve learned as an early access user is that the ³Ô¹Ï±¬ÁÏ AI Quick Check Agent moves Moderna closer to a process where parts of MLR could become nearly touch-free. That¡¯s the vision ¡ª and now we can genuinely see how we might get there.¡±

- Jason Benagh, Global Marketing Operations Director
Moderna

¡°Vault CRM and ³Ô¹Ï±¬ÁÏ AI Agents like Pre-call Agent and Voice Agent will drive efficiencies and allow the field to focus on the value parts of their jobs. It¡¯s good for the business, good for HCPs, and great for patients.¡±

- Frank Armenante, Director, Field Systems and Projects
Novo Nordisk

¡°³Ô¹Ï±¬ÁÏ is a critical system on our transformation roadmap, and it always has been. Being able to share the innovation with the leadership team and to introduce ³Ô¹Ï±¬ÁÏ AI embedded into our ³Ô¹Ï±¬ÁÏ applications is important to us as we expand our partnership.¡±

- Debbie Young, Multichannel Strategy and Customer Insights Director
Otsuka Europe

¡°We¡¯re excited to use the ³Ô¹Ï±¬ÁÏ AI Free Text Agent as part of our strategy toward building AI capabilities into our business. ³Ô¹Ï±¬ÁÏ AI enables us to gain deeper customer insights for more effective engagement in the rare disease space.¡±

- Kea Lingo, Chief Information Officer
Crinetics

¡°Accenture was an early ³Ô¹Ï±¬ÁÏ AI Partner because we believe that ³Ô¹Ï±¬ÁÏ¡¯s unique industry-specific approach to AI will meaningfully increase productivity in life sciences. With our deep expertise in life sciences and proven ability to scale AI, we look forward to working together to ensure customers gain practical value from ³Ô¹Ï±¬ÁÏ AI.¡±

- Craig Robertson, Senior Managing Director, Life Sciences Americas
Accenture

¡°We expect ³Ô¹Ï±¬ÁÏ AI Agents like Free Text Agent and Voice Agent will drive efficiency gains and insight capture that can have a transformative impact on how commercial teams operate into the future. EY is excited to support organizations on this journey toward next generation customer engagement.¡±

- Silvano Perrotta, Partner, Life Sciences Digital Transformation
Ernst & Young AG

About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,500 customers, ranging from the world¡¯s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

³Ô¹Ï±¬ÁÏ Forward-Looking Statements
This release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ¡¯s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2025, which you can find (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at .

###

Contact:

Maria Scurry
³Ô¹Ï±¬ÁÏ Systems
maria.scurry@veeva.com

³Ô¹Ï±¬ÁÏ Commercial Summit, Europe

Copenhagen 2026

Save the Date